Two Sigma Investments’s DNA X Inc SONM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-77
Closed -$100K 4218
2020
Q4
$100K Sell
77
-31
-29% -$33.9K ﹤0.01% 3212
2020
Q3
$151K Buy
108
+77
+248% +$124K ﹤0.01% 2884
2020
Q2
$45K Buy
+31
New +$49.5K ﹤0.01% 2843
2019
Q4
Sell
-13
Closed -$70K 3963
2019
Q3
$70K Buy
13
+2
+18% +$30.7K ﹤0.01% 3336
2019
Q2
$262K Buy
+11
New +$279K ﹤0.01% 2930

Other funds holding SONM

Two Sigma Investments's SONM Position: Q1 2021 in Review

Two Sigma Investments sold out of DNA X Inc (SONM) in Q1 2021, closing a stake of 77 shares — an estimated $100K sold.

Two Sigma Investments first reported a position in SONM in Q2 2019 and held it in 5 quarters. The position peaked at $262K in Q2 2019. 23 funds tracked by Wall St. Rank hold SONM as of Q1 2021.

  • Two Sigma Investments reported no remaining DNA X Inc position as of Q1 2021 after selling out during the quarter.
  • Two Sigma Investments sold 77 DNA X Inc shares in Q1 2021, an estimated $100K.
  • Two Sigma Investments first reported a position in DNA X Inc in Q2 2019 and held it in 5 quarters.
  • Two Sigma Investments's DNA X Inc position peaked at $262K in Q2 2019.
  • 23 funds tracked by Wall St. Rank held DNA X Inc as of Q1 2021.

Based on Two Sigma Investments's 13F filing for Q1 2021, filed 17 May 2021.